Beyond Air (XAIR) Free Cash Flow Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 | 56.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.02% |
| Sep 30, 2025 | 59.96% |
| Jun 30, 2025 | 12.85% |
| Mar 31, 2025 | -0.78% |
| Dec 31, 2024 | -33.37% |
| Sep 30, 2024 | -41.01% |
| Jun 30, 2024 | -48.25% |
| Mar 31, 2024 | -31.32% |
| Dec 31, 2023 | -41.03% |
| Sep 30, 2023 | -61.37% |
| Jun 30, 2023 | -46.32% |
| Mar 31, 2023 | -28.99% |
| Dec 31, 2022 | -24.24% |
| Sep 30, 2022 | -43.47% |
| Jun 30, 2022 | -34.56% |
| Mar 31, 2022 | -46.80% |
| Dec 31, 2021 | 77.04% |
| Sep 30, 2021 | 64.42% |
| Jun 30, 2021 | -19.63% |
| Mar 31, 2021 | -47.25% |
| Dec 31, 2020 | -1.77% |
| Sep 30, 2020 | -38.38% |
| Jun 30, 2020 | -48.57% |
| Mar 31, 2020 | -29.64% |
| Dec 31, 2019 | -158.19% |
| Sep 30, 2019 | -190.23% |
| Jun 30, 2019 | -195.41% |
| Mar 31, 2019 | 239.96% |